ITRM vs RTX · rev $390.0K vs P/E 36, rev $88.60B
Iterum Therapeutics PLC (ITRM) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
ITRM currently screens at market cap $38.6M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the ITRM and RTX stock pages for the full models.
Not investment advice.